Provided by Tiger Trade Technology Pte. Ltd.

DexCom

62.25
-3.8400-5.81%
Post-market: 61.99-0.2600-0.42%19:35 EDT
Volume:4.31M
Turnover:270.27M
Market Cap:23.96B
PE:29.79
High:65.91
Open:65.91
Low:61.99
Close:66.09
52wk High:89.98
52wk Low:54.11
Shares:384.86M
Float Shares:382.00M
Volume Ratio:1.04
T/O Rate:1.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.09
EPS(LYR):2.09
ROE:34.50%
ROA:8.89%
PB:8.72
PE(LYR):29.79

Loading ...

OIG report looks positive for DexCom, says BofA

TIPRANKS
·
Nov 26, 2025

DexCom Initiated at In-Line by Evercore ISI Group

Dow Jones
·
Nov 25, 2025

Evercore Initiates Coverage on DexCom With In Line Rating, $68 Price Target

MT Newswires Live
·
Nov 25, 2025

DexCom Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Nov 25, 2025

Oppenheimer Downgrades DexCom to Perform, Removes $102 Price Target

Reuters
·
Nov 24, 2025

DexCom (DXCM) Valuation in Focus Following Lawsuits Over G6, G7 Design and Regulatory Scrutiny

Simply Wall St.
·
Nov 24, 2025

DexCom Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Nov 22, 2025

Frasers Property UK Secures Dexcom Lease at Maxis Business Park

Reuters
·
Nov 21, 2025

DexCom Launches 15-Day G7 Continuous Glucose Monitor in U.S

Reuters
·
Nov 20, 2025

Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch on Dec. 1 in the United States

THOMSON REUTERS
·
Nov 20, 2025

Dexcom Smart Basal Receives FDA Clearance for CGM-Integrated Insulin Dosing in Type 2 Diabetes

Reuters
·
Nov 19, 2025

Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only Cgm-Integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes

THOMSON REUTERS
·
Nov 19, 2025

DexCom Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Nov 19, 2025

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EST on 2025-11-18

Reuters
·
Nov 19, 2025

DexCom Discloses FDA Warning Over Manufacturing Non-Conformities

Reuters
·
Nov 18, 2025

DexCom Director Richard Alexander Collins Reports Sale of Common Shares

Reuters
·
Nov 18, 2025

DexCom Faces Investor Class Action Over Alleged Securities Fraud

Reuters
·
Nov 18, 2025

DexCom Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Nov 15, 2025

Dexcom Reveals Global Diabetes Advocates: New Voices for Diabetes Awareness This World Diabetes Day

THOMSON REUTERS
·
Nov 14, 2025

Interim CEO of DexCom Jacob Leach Buys 6.6% More Shares

Simply Wall St.
·
Nov 14, 2025